Retraction Note: Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer

  • Keli Su
  • Tingcui Zhang
  • Yongrui Wang
  • Guijun HaoEmail author
Open Access
Retraction Note

Retraction Note: World J Surg Oncol

This article [1] is retracted at the request of Editor-in-Chief due to overlap with articles [2, 3, 4, 5].

None of the authors have responded to any correspondence from the editor or publisher about this retraction.


  1. 1.
    Su K, Zhang T, Wang Y, Hao G. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer. World J Surg Oncol. 2016;14:224 Scholar
  2. 2.
    Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao J, Zhang CY, Wu K, Zhao S. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Biomed Pharmacother. 2016;81:79–85.CrossRefGoogle Scholar
  3. 3.
    Li RZ, Wang LM. RETRACTED ARTICLE: Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma. World J Surg Oncol. 2016;14:150. Scholar
  4. 4.
    Komatsu S, Ichikawa D, Tsujiura M, Konishi H, Takeshita H, Nagata H, Kawaguchi T, Hirajima S, Arita T, Shiozaki A, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res. 2013;33:271–6 Scholar
  5. 5.
    Zhang KC, Xi HQ, Cui JX, Shen WS, Li JY, Wei B, Chen L. Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis. Am J Cancer Res. 2015;5(2):821–9 Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Keli Su
    • 1
  • Tingcui Zhang
    • 2
  • Yongrui Wang
    • 3
  • Guijun Hao
    • 1
    Email author
  1. 1.Department of OncologyThe Fourth People’s Hospital of JinanJinanChina
  2. 2.Department of Internal MedicineThe Central Hospital of JinanJinanChina
  3. 3.Department of Clinical LaboratoryThe Fourth People’s Hospital of JinanJinanChina

Personalised recommendations